Skip to Content
Merck
  • PPM1B negatively regulates antiviral response via dephosphorylating TBK1.

PPM1B negatively regulates antiviral response via dephosphorylating TBK1.

Cellular signalling (2012-07-04)
Yanling Zhao, Li Liang, Yihui Fan, Surong Sun, Lei An, Zhongcheng Shi, Jin Cheng, Wei Jia, Wenjing Sun, Yuko Mori-Akiyama, Hong Zhang, Songbin Fu, Jianhua Yang
ABSTRACT

The production of type I interferon must be tightly regulated and aberrant production of type I interferon is harmful or even fatal to the host. TBK1 phosphorylation at Ser172 plays an essential role in TBK1-mediated antiviral response. However, how TBK1 activity is negatively regulated remains poorly understood. Using a functional genomics approach, we have identified PPM1B as a TBK1 phosphatase. PPM1B dephosphorylates TBK1 in vivo and in vitro. PPM1B wild-type but not its phosphatase-deficient R179G mutant inhibits TBK1-mediated antiviral response and facilitates VSV replication in the cells. Viral infection induces association of PPM1B with TBK1 in a transient fashion in the cells. Conversely, suppression of PPM1B expression enhances virus-induced IRF3 phosphorylation and IFNβ production. Our study identifies a previously unrecognized role for PPM1B in the negative regulation of antiviral response by acting as a TBK1 phosphatase.